BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16565075)

  • 1. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
    Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
    J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation.
    Zeeuwen PL; Ishida-Yamamoto A; van Vlijmen-Willems IM; Cheng T; Bergers M; Iizuka H; Schalkwijk J
    J Invest Dermatol; 2007 Jan; 127(1):120-8. PubMed ID: 16874311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
    Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M
    J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
    Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J
    Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
    Hall A; Håkansson K; Mason RW; Grubb A; Abrahamson M
    J Biol Chem; 1995 Mar; 270(10):5115-21. PubMed ID: 7890620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
    Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
    Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
    Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile.
    Alvarez-Fernandez M; Liang YH; Abrahamson M; Su XD
    J Biol Chem; 2005 May; 280(18):18221-8. PubMed ID: 15728581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase.
    Zeeuwen PL; Van Vlijmen-Willems IM; Jansen BJ; Sotiropoulou G; Curfs JH; Meis JF; Janssen JJ; Van Ruissen F; Schalkwijk J
    J Invest Dermatol; 2001 May; 116(5):693-701. PubMed ID: 11348457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization of cystatin M/E and its target proteases suggests a role in terminal differentiation of human hair follicle and nail.
    Cheng T; van Vlijmen-Willems IM; Hitomi K; Pasch MC; van Erp PE; Schalkwijk J; Zeeuwen PL
    J Invest Dermatol; 2009 May; 129(5):1232-42. PubMed ID: 19005484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
    Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage between phosphorylated cystatin alpha and filaggrin by epidermal transglutaminase as a model of cornified envelope and inhibition of cathepsin L activity by cornified envelope and the conjugated cystatin alpha.
    Takahashi M; Tezuka T; Kakegawa H; Katunuma N
    FEBS Lett; 1994 Mar; 340(3):173-6. PubMed ID: 7907550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the second binding loop of the cysteine protease inhibitor, cystatin A (stefin A), in stabilizing complexes with target proteases is exerted predominantly by Leu73.
    Pavlova A; Björk I
    Eur J Biochem; 2002 Nov; 269(22):5649-58. PubMed ID: 12423365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain.
    Auerswald EA; Nägler DK; Assfalg-Machleidt I; Stubbs MT; Machleidt W; Fritz H
    FEBS Lett; 1995 Mar; 361(2-3):179-84. PubMed ID: 7698319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology of cystatin M/E and its cognate target proteases.
    Zeeuwen PL; Cheng T; Schalkwijk J
    J Invest Dermatol; 2009 Jun; 129(6):1327-38. PubMed ID: 19262604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
    Auerswald EA; Nägler DK; Gross S; Assfalg-Machleidt I; Stubbs MT; Eckerskorn C; Machleidt W; Fritz H
    Eur J Biochem; 1996 Feb; 235(3):534-42. PubMed ID: 8654398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
    Mason RW; Sol-Church K; Abrahamson M
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.